Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com
View Top Employees from Acceleron PharmaWebsite | https://acceleronpharma.com |
Ticker | XLRN |
Revenue | $13 million |
Funding | $231.6 million |
Employees | 174 (174 on RocketReach) |
Founded | 2003 |
Address | 128 Sidney Street, Cambridge, Massachusetts 02139, US |
Phone | (617) 649-9200 |
Fax | (617) 649-9988 |
Technologies |
JavaScript,
HTML,
PHP
+45 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Biopharmaceuticals, Pharmaceuticals, Science and Engineering, Orphan Disease Therapeutics, Healthcare, Health Care, Cancer Therapeutics, Medical |
Web Rank | 1 Million |
Keywords | Acceleron Pharma, Acceleron, Luspatercept, Acceleron Pharma Inc, Sopatercept Acceleron |
Competitors | Altus Technologies Corporation, Complix N.V., MyoKardia, Orphazyme A/S, Reata Pharmaceuticals, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Acceleron Pharma employee's phone or email?
The Acceleron Pharma annual revenue was $13 million in 2024.
Steve Ertel is the COO of Acceleron Pharma.
174 people are employed at Acceleron Pharma.
Acceleron Pharma is based in Cambridge, Massachusetts.
The NAICS codes for Acceleron Pharma are [32541, 325, 3254, 32].
The SIC codes for Acceleron Pharma are [283, 28].